Brisbane, CA · Health Care · Form D filed Oct 14, 2026
Tempest Therapeutics, Inc. raised $7.5M
Tempest Therapeutics, Inc. is a biotechnology company based in Brisbane, California. In a Form D filed with the SEC on October 14, 2026, it reported raising $7,500,000 from 1 investor as part of an offering of up to $7,500,000. The first sale in the offering took place on September 15, 2026.
In the news: Investing News: Tempest Therapeutics Announces Up to $7.5 Million Private Placement
- 5th Form D since 2013. Earlier new notices: Jun 23, 2026 · Apr 3, 2026 · May 11, 2022 · Mar 28, 2013. All filings on EDGAR
$28.6M raised since 2020
4 Form D offerings, as reported to the SEC, the first in May 11, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 14, 2026 | $7.5M | $7.5M | 1 |
| Jun 23, 2026 | $4.1M | $4.1M | 1 |
| Apr 3, 2026 | $2M | $2M | 3 |
| May 11, 2022 | $15M | $15M | 2 |
Placement agent: H.C. Wainwright & Co., LLC
Lead score
28 out of 100
filed this week budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $7,500,000
- Offering size
- $7,500,000
- Investors so far
- 1
- First sale
- September 15, 2026
- Securities offered
- Options or warrants, Securities issuable on exercise or conversion, Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Brisbane, California
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $7,500,000 | $7,500,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Oct 12, 2026 · Health Care funding in California
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
Renue Life Sciences, Inc.
San Carlos, CA · filed Oct 14First Form DStill raising
iPill Inc.
Rowland Heights, CA · filed Oct 132nd Form D since 2025Still raising
White Eagle Sonic Technologies, Inc.
Santa Clara, CA · filed Oct 135th Form D since 2012Still raising
Digestive Disease Center, L.P.
Laguna Hills, CA · filed Oct 83rd Form D since 2022
Lionheart Health, Inc.
Huntington Beach, CA · filed Oct 7First Form DStill raising
Anvion Bio, Inc.
San Diego, CA · filed Oct 7First Form DStill raising